Advanced Search

 

Study ID Status Title Patient Level Data
OM5 program (Reliant) Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Omacor Therapy in Hypertriglyceridemic Subjects Treated with Antara, followed by an 8-week extension Study Listed on ClinicalStudyDataRequest.com
OM6 program (Reliant) Completed A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Combined Omacor and Simvastatin Therapy in Hypertriglyceridemic Subjects Study Listed on ClinicalStudyDataRequest.com
OM8 Afib Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Lovaza for the Prevention of Recurrent, Symptomatic Atrial Fibrillation Study Listed on ClinicalStudyDataRequest.com
OM9L Completed A Randomized, Double-Blind, Placebo-Controlled, Forced Titration Study to Assess the Efficacy and Safety of Omacor, Co-Administered with Open-Label Atorvastatin Therapy, in Hypertriglyceridemic Subjects Study Listed on ClinicalStudyDataRequest.com
OMB_HX_CD20_001 Completed An open-label, international, multicenter, dose escalating, Phase I/II study of HuMax-CD20 in patients with relapsed or refractory follicular lymphoma grade I-II
OMB_HX_CD20_402 Completed An open label, international, multicenter, dose-escalating Phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory Chronic Lymphocytic Leukemia.
OMB110911 Active, Not Recruiting A phase III, open label, randomized, multicenter trial of Ofatumumab added to Chlorambucil versus Chlorambucil Monotherapy in previously untreated patients with Chronic Lymphocytic Leukemia
OMB111148 Completed An open-label phase I study of ofatumumab (GSK1841157) in Japanese patients with CD20 positive follicular lymphoma or chronic lymphocytic leukemia
ONDA0801 Completed Oral Ondansetron Regimen vs Alizapride Injection and Tablet Regimen in the Prophylaxis of Emesis Induced by Chemotherapy in Breast Cancer
OTA105256 Completed A randomized, double-blind, placebo-controlled, dose ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously and to investigate the pharmacokinetics of GSK221149A administered orally to healthy, pregnant females with uncomplicated pre-term labor between 300/7 and 356/7 weeks’ gestation Study Listed on ClinicalStudyDataRequest.com
OTP108172 Completed A randomized, double-blind, placebo-controlled, two-session study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an 16448 in healthy males with premature ejaculation.
OXS104092 Completed A single-blind, randomised, placebo-controlled, 15 day repeated-dose study to evaluate the safety, tolerability and pharmacokinetics of SB-649868 and its interaction with the CYP3A4 isoenzyme in healthy male subjects.
OXS104094 Completed A Double-blind, double-dummy, randomised, placebo-controlled,four-way crossover study to investigate the effect of single oral doses of SB-649868 and of Zolpidem in a model of noise induced situational insomnia in healthy male volunteers.
OXS105205 Completed A single-centre, open-label, randomized, single-dose, 6-way crossover study to investigate the pharmacokinetics, safety and tolerability of 6 different formulations of SB-649868 30 mg (Part A) and the effect of food on the selected formulation of SB-649868 pharmacokinetic (Part B) in healthy male volunteers
OXS107714 Completed A multi-centre, randomized, double-blind, placebo-controlled, cross-over study to evaluate the effects of SB-649868 (10, 30 mg and 60 mg) on sleep continuity, PSG sleep recordings, subjective sleep assessment, and daytime cognitive function in subjects with primary insomnia
OXS109139 Completed An open-label study to determine the excretion, balance and pharmacokinetics of SB649868 after a single oral administration of 14C-SB649868 in healthy volunteers
P02-027 Completed A Single Dose Metabolism Study of 14C-Wellbutrin in Normal Volunteers
P02-24 Completed Phase I - A comparison of bupropion, dextroamphetamine and placebo for abuse liability in amphetamine abusers
P02-31UK Completed Examination of Bupropion and Ethanol, Alone and in Combination, on Human Performance Tests, Subjective Rating Scales, EEG and Autonomic Responses
P02-36UK Completed Investigation of the Effects of Bupropion and Imipramine on the Blood Pressure Response to Tyramine in Man
P02-37UK Completed Comparison of the Effects of Bupropion, Nomifensine, and Dextroamphetamine on Performance Tests, Subjective Scales, Autonomic Responses, and Electroencephalograms in Healthy Human Volunteers
P1653 Completed A single rising dose study of the safety, tolerability, pharmacokinetics & pharmacodynamics of subcutaneous SR90107A/ORG31540 natural pentasaccaride in healthy male volunteers
P2200313 Completed A safety study of a topical corticosteroid cream in pediatric subjects aged 3 years to 5 years 11 months with atopic dermatitis
P2200314 Completed A safety study of a topical corticosteroid cream in pediatric subjects aged 3 months to 35 months with atopic dermatitis
P2200440 Completed A Mult-Center, Open-Label Study to Evaluate Product Duration of Use Experience with Aclometasone Diproprionate Cream

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.